These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17367069)

  • 21. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
    Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
    Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.
    Wang H; Wang S; Nan L; Yu D; Agrawal S; Zhang R
    Int J Oncol; 2002 Apr; 20(4):745-52. PubMed ID: 11894120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas.
    Tong Y; Mentlein R; Buhl R; Hugo HH; Krause J; Mehdorn HM; Held-Feindt J
    J Neurochem; 2007 Feb; 100(4):1097-107. PubMed ID: 17181554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An orthotopic skull base model of malignant meningioma.
    Baia GS; Dinca EB; Ozawa T; Kimura ET; McDermott MW; James CD; VandenBerg SR; Lal A
    Brain Pathol; 2008 Apr; 18(2):172-9. PubMed ID: 18093250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
    Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.
    Skibinski CG; Williamson T; Riggins GJ
    J Neurooncol; 2018 Dec; 140(3):529-538. PubMed ID: 30414098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.
    Ragel BT; Elam IL; Gillespie DL; Flynn JR; Kelly DA; Mabey D; Feng H; Couldwell WT; Jensen RL
    J Neurosurg; 2008 Feb; 108(2):304-10. PubMed ID: 18240927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
    Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
    Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.
    Prewett MC; Hooper AT; Bassi R; Ellis LM; Waksal HW; Hicklin DJ
    Clin Cancer Res; 2002 May; 8(5):994-1003. PubMed ID: 12006511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
    Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM
    Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
    Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
    Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model.
    Guichard SM; Hua ML; Kang P; Macpherson JS; Jodrell DI
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):651-60. PubMed ID: 17273826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.